Silence Therapeutics (SLN) Net Cash Flow (2020 - 2025)
Historic Net Cash Flow for Silence Therapeutics (SLN) over the last 6 years, with Q3 2025 value amounting to $40.4 million.
- Silence Therapeutics' Net Cash Flow rose 17309.18% to $40.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 million, marking a year-over-year decrease of 11929.02%. This contributed to the annual value of $52.5 million for FY2024, which is 116348.37% up from last year.
- Per Silence Therapeutics' latest filing, its Net Cash Flow stood at $40.4 million for Q3 2025, which was up 17309.18% from -$23.4 million recorded in Q2 2025.
- In the past 5 years, Silence Therapeutics' Net Cash Flow registered a high of $74.9 million during Q1 2024, and its lowest value of -$56.7 million during Q1 2025.
- In the last 5 years, Silence Therapeutics' Net Cash Flow had a median value of -$4.3 million in 2024 and averaged $2.6 million.
- Examining YoY changes over the last 5 years, Silence Therapeutics' Net Cash Flow showed a top increase of 1670649.72% in 2022 and a maximum decrease of 125310.96% in 2022.
- Over the past 5 years, Silence Therapeutics' Net Cash Flow (Quarter) stood at $3.0 million in 2021, then crashed by 1253.11% to -$34.9 million in 2022, then surged by 72.37% to -$9.6 million in 2023, then soared by 499.44% to $38.5 million in 2024, then grew by 4.78% to $40.4 million in 2025.
- Its Net Cash Flow stands at $40.4 million for Q3 2025, versus -$23.4 million for Q2 2025 and -$56.7 million for Q1 2025.